Trogarzo

ibalizumab · TaiMed Biologics Inc.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Trogarzo, covering 2016-11-01 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection [Phase 3]